Summary
The response of the norepinephrine (NE) sensitive cyclic AMP generating system in slices of the rat limbic forebrain after both the acute and chronic administration of the tricyclic antidepressants desipramine (DMI) and iprindole as well as electroconvulsive treatment (ECT) was investigated. Neither the basal level of cyclic AMP nor the hormonal response to NE were altered after the administration of a single dose or short term treatment with DMI and iprindole. However, the administration of the antidepressants on a clinically more relevant time basis markedly reduced the sensitivity of the cyclic AMP generating system to NE. This change in sensitivity was not related to the levels of the drugs in brain. The response of cyclic AMP to NE was also reduced by ECT, but the onset of this action was shorter than that observed with the antidepressants. ECT also antagonized the enhanced response of cyclic AMP to NE following destruction of central adrenergic nerve terminals with 6-hydroxydopamine. It thus appears that the therapeutic action of tricyclic antidepressants could be related to postsynaptic adaptive changes in the sensitivity of the noradrenergic adenylate cyclase receptor system rather than to acute presynaptic events.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ayd, F. J.: Clinical evaluation of a new tricyclic antidepressant iprindole. Dis. nerv. Syst. 30, 818–824 (1969)
Bliss, E. L., Ailion, T., Zwanziger, J.: Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress. J. Pharmacol. exp. Ther. 164, 122–134 (1968)
Blumberg, J. B. Taylor, R. E., Sulser, F.: Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: Possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics. J. Pharm. Pharmacol. 27, 125–128 (1975)
Blumberg, J. B., Vetulani, J., Stawarz, R. J., Sulser, F.: The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics. Europ. J. Pharmacol. (in press, 1976)
Bunney, W. E., Davis, J. M.: Norepinephrine in depressive reactions. Arch. gen. Psychiat. 13, 484–494 (1965)
Chang, C. C.: A sensitive method for spectrophotofluorometric assay of catecholamines. Int. J. Neuropharmacol. 3, 643–649 (1964)
Deguchi, T., Axelrod, J.: Supersensitivity and subsensitivity of β-adrenergic receptor in pineal gland regulated by catecholamine transmitter. Proc. nat. Acad. Sci. (Wash.) 70, 2411–2414 (1973)
Denber, H. C. B.: Pharmacotherapy of depression. In: Psychopharmacological treatment—theory and practice (H. C. B. Denber, ed.), pp. 121–134. New York: Marcel Dekker 1975
Dingell, J. V., Sulser, F., Gillette, J. R.: Species differences in the metabolism of imipramine and desmethylimipramine. J. Pharmacol. exp. Ther. 143, 14–23 (1964)
Frazer, A., Pandey, G., Mendels, J., Neeleg, S., Kane, M., Hess, M. E.: The effect of triodothyronine in combination with imipramine on 3H-cyclic AMP production in slices of rat cerebral cortex. Neuropharmacology 13, 1131–1140 (1974)
Freeman, J. J., Sulser, F.: Iprindole-amphetamine interactions in the rat: The role of aromatic hydroxylation of amphetamine in its mode of action. J. Pharmacol. exp. Ther. 183, 307–315 (1972)
Gilman, A. G.: A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc. nat. Acad. Sci. (Wash.) 67, 305–312 (1970)
Hendley, E. D., Welch, B. L.: Electroconvulsive shock: Sustained decrease in norepinephrine uptake in a reserpine model of depression. Life Sci. 16, 45–54 (1975)
Hicks, J. T.: Iprindole, a new antidepressant for use in general office practice. Ill. med. J. 128, 622–626 (1975)
Lahti, R. A., Maickel, R. P.: The tricyclic antidepressants-inhibition of norepinephrine uptake as related to potentiation of norepinephrine and clinical efficacy. Biochem. Pharmacol. 20, 482–486 (1971)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Makman, M. H.: Properties of adenylate cyclase of lymphoid cells. Proc. nat. Acad. Sci. (Wash.) 68, 885–889 (1971)
Matussek, M., Ladisich, W.: Chronic administration of electroconvulsive shock and norepinephrine metabolism in the rat brain. III. Influence of acute and chronic electroshock upon drug induced behavior. Psychopharmacologia (Berl.) 15, 305–309 (1969)
McClatchey, W. T., Moffat, T., Irvine, G. M.: A double blind study of WY 3263, imipramine and placebo. J. ther. clin. Res. 1, 13–19 (1967)
McKinney, W. T.: Animal models in psychiatry. Biol. Med. 17, 529–541 (1974)
MuKherjee, C., Caron, M., Lefkowitz, R. J.: Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of β-adrenergic receptor sites. Proc. nat. Acad. Sci. (Wash.) 72, 1945–1949 (1975)
Palmer, G. C., Robison, G. A., Manian, A. A., Sulser, F.: Modification by psychotropic drugs of the cyclic AMP response to norepinephrine in the rat brain in vitro. Psychopharmacologia (Berl.) 23, 201–211 (1972)
Papeschi, R. A., Randrup, A., Lal, S.: Effect of ECT on dopaminergic and noradrenergic mechanisms. Psychopharmacologia (Berl.) 35, 149–158 (1974)
Rickels, K., Chung, H., Csanalosi, I., Sablosky, W., Simon, J.: Iprindole and imipramine in non-psychotic depressed out-patients. Brit. J. Psychiat. 123, 329–339 (1973)
Rosloff, B. N., Davis, J. M.: Effect of iprindole on norepinephrine turnover and transport. Psychopharmacologia (Berl.) 40, 53–64 (1974)
Schildkraut, J. J.: The catecholamine hypothesis of affective disorders. A review of supporting evidence. Amer. J. Psychiat. 122, 509–522 (1965)
Schildkraut, J. J., Kety, S. S.: Biogenic amines and emotion. Science 156, 21–30 (1967)
Segal, D. S., Kuczenski, R., Mandell, A. J.: Theoretical implications of drug induced adaptive regulation for a biogenic amine hypothesis of affective disorder. Biol. Psychiat. 9, 147–159 (1974)
Sterlin, C., Lehmann, H. E., Oliveros, R. F.: A preliminary investigation of WY-3263 versus amitriptyline in depression. Curr. ther. Res. 10, 576–582 (1968)
Sulser, F.: The mode of action of antidepressants. In: Psychopharmacological treatment — Theory and practice (H. C. B. Denber, ed.), pp. 97–120. New York: Marcel Dekker 1975
Thierry, A. M., Javoy, F., Glowinski, J., Kety, S. S.: Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J. Pharmacol. exp. Ther. 163, 163–171 (1968)
Vetulani, J., Stawarz, R. J., Sulser, F.: Adaptive mechanisms of the noradrenergic cyclic AMP generating system in limbic forebrain of the rat: Adaptation to persistent changes in the availability of norepinephrine. J. Neurochem. (in press, 1976)
Vetulani, J., Sulser, F.: Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature (Lond.) 257, 495–496 (1975)
Vetulani, J., Reichenberg, K., Wiszniowska, G.: The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide pretreated rats. Psychopharmacologia (Berl.) 38, 173–180 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vetulani, J., Stawarz, R.J., Dingell, J.V. et al. A possible common mechanism of action of antidepressant treatments. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, 109–114 (1976). https://doi.org/10.1007/BF00499215
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499215